Ways to Give: How You Can Donate Your Birthday Through Facebook
…supporting research to find the cure for melanoma. #EndMelanoma Create your birthday fundraiser When you start a nonprofit fundraiser on…
Ways to Give: How You Can Donate Your Birthday Through Facebook
…supporting research to find the cure for melanoma. #EndMelanoma Create your birthday fundraiser When you start a nonprofit fundraiser on…
,
New Specialty Manages Skin Concerns and Keeps Patients on Therapy
Cancer treatment—including and especially melanoma—unfortunately, produces a risk of side effects impacting the feeling and vitality of the skin. Changes…
,
Side Effect Central – Colitis
…on your website? https://www.aimatmelanoma.org/melanoma-learning-center/side-effect-management-guides/ https://themelanomanurse.org/side-effect-search-section/ https://www.aimatmelanoma.org/wp-content/uploads/AIM-YERVOY-MULTIPAGE.pdf https://www.aimatmelanoma.org/wp-content/uploads/AIM-OPDIVO-YERVOY-MULTIPAGE-1.pdf https://www.youtube.com/playlist?list=PLOnM_erAQqICO-gEouc_MRXGzcFBVC0Il References: Frey C and Etminan M. Adverse Events of PD-1, PD-L1,…
,
Ways to Give: Monthly Giving
Sixth Article in a Series Are you familiar with The Supporters Guild, AIM’s Monthly Giving Program? It empowers you to…
,
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
…melanoma cohort of the IGNYTE clinical trial. “Today is an important milestone for Replimune and for the melanoma community as…
,
Results Prove Immunotherapy Should be the Initial Treatment for BRAF Mutant Tumors
…BRAF mutant melanoma. This study is called “Dream Seq,” and readers might recall that the initial results were revealed at…
,
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
…personalized vaccine continued to cut the risk of death or recurrence of the most deadly skin cancer five years after…
,
Survivorship: Living Well with Melanoma
…Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.…
,
Melanoma Survivor Angela Evatt: Consider a Clinical Trial for Yourself
…cousin, who is a physician, Angela secured a dermatology appointment in Louisiana. “The dermatologist looked at it, promptly biopsied it,…
,
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
…treatment of advanced melanoma in patients who progress on an anti-PD-1 containing regimen. The PDUFA date set by the FDA…
,
Recent Posts
Aug. 31, 2026
Women in Melanoma: A New Chapter in Europe
Aug. 31, 2026
The Legal & Financial Side of a Diagnosis: What No One Tells You
Aug. 19, 2026
Positive Phase 3 Results for Personalized mRNA Therapy in Melanoma
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 06, 2026